MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Klinger, M.
Right arrow Articles by Hohenegger, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Klinger, M.
Right arrow Articles by Hohenegger, M.

Vol. 55, Issue 3, 462-472, March 1999

Suramin and Suramin Analogs Activate Skeletal Muscle Ryanodine Receptor via a Calmodulin Binding Site

Markus Klinger, Michael Freissmuth, Peter Nickel, Margit Stäbler-Schwarzbart, Matthias Kassack, Josef Suko, and Martin Hohenegger

Institute of Pharmacology, University of Vienna, Vienna, Austria (M. Kl, M.F., J.S., M.H.); and the Institute of Pharmaceutical Chemistry, University of Bonn, Bonn, Germany (P.N., M.S.-S., M. Ka)

Contraction of skeletal muscle is triggered by the rapid release of Ca2+ from the sarcoplasmic reticulum via the ryanodine receptor/calcium-release channel. The trypanocidal drug suramin is an efficient activator of the ryanodine receptor. Here, we used high-affinity [3H]ryanodine binding to sarcoplasmic reticulum from rabbit skeletal muscle to screen for more potent analogs of suramin. This approach resulted in the identification of NF307, which accelerates the association rate of [3H]ryanodine binding with an EC50 = 91 ± 7 µM at 0.19 µM calculated free Ca2+. In single-channel recordings with the purified ryanodine receptor, NF307 increased mean open probability at 0.6 µM Ca2+ from 0.020 ± 0.006 to 0.53 ± 0.07 with no effect on current amplitude and unitary conductance. Like caffeine, NF307 exerts a very pronounced Ca2+-sensitizing effect (EC50 of Ca2+ shifted ~10-fold by saturating NF307 concentrations). Conversely, increasing concentrations of free Ca2+ sensitized the receptor for NF307 (EC50 = 14.6 ± 3.5 µM at 0.82 µM estimated free Ca2+). The effects of NF307 and caffeine on [3H]ryanodine binding were additive, irrespective of the Ca2+ concentration. In contrast, the effects of calmodulin, which activates and inhibits the ryanodine receptor in the absence and presence of Ca2+, respectively, and of NF307 were mutually antagonistic. If the purified ryanodine receptor was prebound to a calmodulin-Sepharose matrix, 100 µM NF307 and 300 µM suramin eluted the purified ryanodine receptor to an extent that was comparable to the effect of 10 µM calmodulin. We conclude that NF307 and suramin interact directly with a calmodulin binding domain of the ryanodine receptor. Because of its potent calcium-sensitizing effect, NF307 may represent a lead compound in the search of synthetic ryanodine receptor ligands.

Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
J. Sacher, L. Weigl, M. Werner, C. Szegedi, and M. Hohenegger
Delineation of Myotoxicity Induced by 3-Hydroxy-3-methylglutaryl CoA Reductase Inhibitors in Human Skeletal Muscle Cells
J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 1032 - 1041.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
N. Nadif Kasri, G. Bultynck, J. B. Parys, G. Callewaert, L. Missiaen, and H. De Smedt
Suramin and Disulfonated Stilbene Derivatives Stimulate the Ca2+-Induced Ca2+-Release Mechanism in A7r5 Cells
Mol. Pharmacol., July 1, 2005; 68(1): 241 - 250.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
A. P. Hill, O. Kingston, and R. Sitsapesan
Functional Regulation of the Cardiac Ryanodine Receptor by Suramin and Calmodulin Involves Multiple Binding Sites
Mol. Pharmacol., May 1, 2004; 65(5): 1258 - 1268.
[Abstract] [Full Text]

Home page
 Biophys. JHome page
E. R. O'Neill, M. M. Sakowska, and D. R. Laver
Regulation of the Calcium Release Channel from Skeletal Muscle by Suramin and the Disulfonated Stilbene Derivatives DIDS, DBDS, and DNDS
Biophys. J., March 1, 2003; 84(3): 1674 - 1689.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. V. L. Papineni, K. M. S. O'Connell, H. Zhang, R. T. Dirksen, and S. L. Hamilton
Suramin Interacts with the Calmodulin Binding Site on the Ryanodine Receptor, RYR1
J. Biol. Chem., December 13, 2002; 277(51): 49167 - 49174.
[Abstract] [Full Text] [PDF]

Home page
 Biophys. JHome page
A. P. Hill and R. Sitsapesan
DIDS Modifies the Conductance, Gating, and Inactivation Mechanisms of the Cardiac Ryanodine Receptor
Biophys. J., June 1, 2002; 82(6): 3037 - 3047.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
J. Suko, G. Hellmann, and H. Drobny
Short- and Long-Term Functional Alterations of the Skeletal Muscle Calcium Release Channel (Ryanodine Receptor) by Suramin: Apparent Dissociation of Single Channel Current Recording and [3H]Ryanodine Binding
Mol. Pharmacol., March 1, 2001; 59(3): 543 - 556.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Cell Physiol.Home page
B. R. Fruen, J. M. Bardy, T. M. Byrem, G. M. Strasburg, and C. F. Louis
Differential Ca2+ sensitivity of skeletal and cardiac muscle ryanodine receptors in the presence of calmodulin
Am J Physiol Cell Physiol, September 1, 2000; 279(3): C724 - C733.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics